LYMPHOMATOID PAPULOSIS
Clinical trials for LYMPHOMATOID PAPULOSIS explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMATOID PAPULOSIS trials appear
Sign up with your email to follow new studies for LYMPHOMATOID PAPULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a lower dose of this cancer drug be just as effective?
Disease control Recruiting nowThis study is testing a lower dose of the drug brentuximab vedotin in people with mycosis fungoides, Sezary syndrome, or lymphomatoid papulosis—types of lymphoma that affect the skin. The goal is to see if the lower dose works as well as the standard dose but with fewer side effe…
Matched conditions: LYMPHOMATOID PAPULOSIS
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
Researchers track lifelong effects of rare childhood skin lymphomas
Knowledge-focused Recruiting nowThis study follows 100 people who were diagnosed with juvenile-onset mycosis fungoides or lymphomatoid papulosis before age 20. Researchers will check their health status and ask them or their parents about long-term outcomes. The goal is to understand the safety and long-term ef…
Matched conditions: LYMPHOMATOID PAPULOSIS
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 03:34 UTC
-
Scientists launch tissue collection to unlock lymphoma mysteries
Knowledge-focused Recruiting nowThis study collects and stores tissue samples from people with cutaneous T-cell lymphoma (CTCL) and healthy volunteers. Researchers will use these samples to study changes in T-cells that drive the disease. No treatment or intervention is given—the goal is to build a resource for…
Matched conditions: LYMPHOMATOID PAPULOSIS
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated May 26, 2026 03:34 UTC